Kistler-Tiffany Companies’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.4M | Buy |
10,803
+50
| +0.5% | +$11.6K | 0.39% | 49 |
|
|
2023
Q1 | $2.6M | Buy |
10,753
+7
| +0.1% | +$1.72K | 0.49% | 37 |
|
|
2022
Q4 | $2.82M | Buy |
10,746
+88
| +0.8% | +$23.6K | 0.58% | 32 |
|
|
2022
Q3 | $2.4M | Sell |
10,658
-143
| -1% | -$34.7K | 0.55% | 32 |
|
|
2022
Q2 | $2.63M | Buy |
10,801
+493
| +5% | +$121K | 0.57% | 33 |
|
|
2022
Q1 | $2.49M | Sell |
10,308
-81
| -0.8% | -$18.6K | 0.47% | 37 |
|
|
2021
Q4 | $2.34M | Buy |
10,389
+32
| +0.3% | +$6.75K | 0.46% | 39 |
|
|
2021
Q3 | $2.2M | Buy |
10,357
+436
| +4% | +$100K | 0.5% | 37 |
|
|
2021
Q2 | $2.42M | Sell |
9,921
-1,842
| -16% | -$453K | 0.56% | 32 |
|
|
2021
Q1 | $2.93M | Sell |
11,763
-72
| -0.6% | -$17.2K | 0.76% | 26 |
|
|
2020
Q4 | $2.72M | Sell |
11,835
-68
| -0.6% | -$15.7K | 0.78% | 27 |
|
|
2020
Q3 | $3.02M | Sell |
11,903
-255
| -2% | -$63.2K | 0.97% | 21 |
|
|
2020
Q2 | $2.87M | Sell |
12,158
-266
| -2% | -$60.7K | 1.02% | 19 |
|
|
2020
Q1 | $3M | Hold |
12,424
| – | – | 1.06% | 19 |
|
|
2019
Q4 | $3M | Sell |
12,424
-137
| -1% | -$30.2K | 1.05% | 19 |
|
|
2019
Q3 | $2.43M | Buy |
12,561
+80
| +0.6% | +$15.4K | 0.92% | 18 |
|
|
2019
Q2 | $2.3M | Sell |
12,481
-60
| -0.5% | -$10.7K | 0.87% | 19 |
|
|
2019
Q1 | $2.38M | Sell |
12,541
-372
| -3% | -$71K | 0.99% | 16 |
|
|
2018
Q4 | $2.51M | Sell |
12,913
-141
| -1% | -$27.5K | 1.17% | 15 |
|
|
2018
Q3 | $2.71M | Sell |
13,054
-172
| -1% | -$33.9K | 1.12% | 14 |
|
|
2018
Q2 | $2.44M | Sell |
13,226
-655
| -5% | -$116K | 1.08% | 14 |
|
|
2018
Q1 | $2.37M | Sell |
13,881
-711
| -5% | -$131K | 0.97% | 16 |
|
|
2017
Q4 | $2.54M | Buy |
14,592
+428
| +3% | +$75.7K | 1% | 17 |
|
|
2017
Q3 | $2.64M | Buy |
14,164
+1,174
| +9% | +$208K | 1.1% | 14 |
|
|
2017
Q2 | $2.24M | Buy |
12,990
+962
| +8% | +$156K | 1.03% | 20 |
|
|
2017
Q1 | $1.97M | Buy |
12,028
+425
| +4% | +$70.6K | 0.93% | 21 |
|
|
2016
Q4 | $1.7M | Sell |
11,603
-760
| -6% | -$114K | 0.83% | 26 |
|
|
2016
Q3 | $2.06M | Sell |
12,363
-16
| -0.1% | -$2.71K | 1.02% | 23 |
|
|
2016
Q2 | $1.88M | Sell |
12,379
-51
| -0.4% | -$7.93K | 0.97% | 23 |
|
|
2016
Q1 | $1.86M | Sell |
12,430
-203
| -2% | -$30.2K | 1.04% | 22 |
|
|
2015
Q4 | $2.05M | Buy |
12,633
+400
| +3% | +$62.9K | 1.13% | 21 |
|
|
2015
Q3 | $1.69M | Sell |
12,233
-65
| -0.5% | -$10.2K | 1.01% | 22 |
|
|
2015
Q2 | $1.89M | Sell |
12,298
-102
| -0.8% | -$16.3K | 1.13% | 18 |
|
|
2015
Q1 | $1.98M | Hold |
12,400
| – | – | 1.26% | 17 |
|
|
2014
Q4 | $1.98M | Sell |
12,400
-17
| -0.1% | -$2.65K | 1.29% | 17 |
|
|
2014
Q3 | $1.74M | Sell |
12,417
-70
| -0.6% | -$9.14K | 1.16% | 19 |
|
|
2014
Q2 | $1.48M | Buy |
12,487
+4
| +0% | +$463 | 1.07% | 20 |
|
|
2014
Q1 | $1.54M | Sell |
12,483
-216
| -2% | -$26.2K | 1.15% | 18 |
|
|
2013
Q4 | $1.45M | Buy |
12,699
+3
| +0% | +$341 | 1.09% | 19 |
|
|
2013
Q3 | $1.42M | Buy |
12,696
+6
| +0% | +$651 | 1.15% | 21 |
|
|
2013
Q2 | $1.25M | Buy |
+12,690
| New | +$1.32M | 1.07% | 23 |
|
Other funds holding AMGN
Kistler-Tiffany Companies's AMGN Position: Q2 2023 in Review
Kistler-Tiffany Companies increased its Amgen (AMGN) stake by 0.46% in Q2 2023, buying an estimated $11.6K and bringing the position to 10,803 shares worth $2.4M. The position accounts for 0.39% of the portfolio, ranked #49.
Kistler-Tiffany Companies first reported a position in AMGN in Q2 2013 and has held it in 41 quarters since. The position peaked at $3.02M in Q3 2020. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.
- Kistler-Tiffany Companies held 10,803 shares of Amgen worth $2.4M as of Q2 2023.
- Kistler-Tiffany Companies bought 50 Amgen shares in Q2 2023, an estimated $11.6K.
- Amgen made up 0.39% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #49 holding.
- Kistler-Tiffany Companies first reported a position in Amgen in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's Amgen position peaked at $3.02M in Q3 2020.
- 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.